Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
No:10124 Insulin Glulisine
Injection Monocomponent Insulin Glulisine
100 Units/Ml 3 Ml Pfs
the addition of rapid-acting insulin glulisine
with or without metformin injected once daily at the time of the patient's main meal (basal-plus), or three times daily at meal time (basal-bolus).
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine
while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.
Rapid-acting insulin analogs include insulin aspart (NovoLog[R]), insulin lispro (Humalog[R]), and insulin glulisine
A third insulin analog on the market, insulin glulisine
(Apidra), approved in 2004, has a pharmacokinetic profile that is similar to insulin aspart and lispro, but Mr.
A10AB06 Insulin glulisine
Apidra Solostar 100U/ml 3 ml 10.
(Category C) has limited evidence of safe use in pregnancy.
Lankisch et al showed that in patients suboptimally controlled on basal insulin glargine, the addition of a single injection of insulin glulisine
at breakfast or at the meal with the highest postprandial excursion was equally effective in reducing the A1C level.
(Apidra [R]) 20 minutes after meal in combination with basal insulin analog